Neuroprotective effects of catechins in an experimental Parkinson’s disease model and SK-N-AS cells: evaluation of cell viability, anti-inflammatory and anti-apoptotic effects
dc.contributor.author | Özduran G. | |
dc.contributor.author | Becer E. | |
dc.contributor.author | Vatansever H.S. | |
dc.contributor.author | Yücecan S. | |
dc.date.accessioned | 2024-07-22T08:05:07Z | |
dc.date.available | 2024-07-22T08:05:07Z | |
dc.date.issued | 2022 | |
dc.description.abstract | Objectives: The aim of the study was to establish an in vitro Parkinson’s disease (PD) model and to investigate the cell viability, anti-inflammatory, anti-apoptotic and neuroprotective effects of catechin and EGCG in SK-N-AS and in vitro PD model cells. Method: SK-N-AS human neuroblastoma cells were used. To develop an in vitro PD model, SK-N-AS cells were exposed to 6-hydroxydopamine. Model control was performed after ELISA analysis of dopamine and α-synuclein levels in the culture medium. Catechin and EGCG were administered to SK-N-AS and in vitro PD model cells. Cell viability was measured using MTT assay and trypan blue staining. Anti-inflammatory and anti-apoptotic activities of catechin and EGCG were investigated by indirect immunocytochemistry using anti-TNF-α, anti-IL-1β and anti-caspase-3. Results: After 24 hours of 6-hydroxydopamine administration at 50 μM, higher αlfa-synuclein and lower dopamine levels were found in PD model than SK-N-AS cells. Cell viability was similar between SK-N-AS and in vitro PD model cells. Treatment with both bioactive components increased cell viability of in vitro PD model cells. Caspase-3 immunoreactivity was significantly reduced in SK-N-AS and PD model cells after EGCG administration, while it was decreased only in PD model cells after catechin administration. IL-1β staining intensity weakened after catechin administration in PD model cells, after EGCG administration in SK-N-AS cells. TNF-α staining intensity was similar in both cells. Conclusion: Catechin and EGCG increased cell viability in PD model neuron cells. Both components showed anti-apoptotic and anti-inflammatory effects. Catechin may be more effective in preventing damage to neurons PD. © 2022 Informa UK Limited, trading as Taylor & Francis Group. | |
dc.identifier.DOI-ID | 10.1080/01616412.2021.2024715 | |
dc.identifier.issn | 01616412 | |
dc.identifier.uri | http://akademikarsiv.cbu.edu.tr:4000/handle/123456789/12977 | |
dc.language.iso | English | |
dc.publisher | Taylor and Francis Ltd. | |
dc.subject | Anti-Inflammatory Agents | |
dc.subject | Apoptosis | |
dc.subject | Catechin | |
dc.subject | Cell Survival | |
dc.subject | Dopamine | |
dc.subject | Humans | |
dc.subject | Neuroprotective Agents | |
dc.subject | Oxidopamine | |
dc.subject | Parkinson Disease | |
dc.subject | Tumor Necrosis Factor Inhibitors | |
dc.subject | 3 (4,5 dimethyl 2 thiazolyl) 2,5 diphenyltetrazolium bromide | |
dc.subject | alpha synuclein | |
dc.subject | c0567 | |
dc.subject | caspase 3 | |
dc.subject | catechin | |
dc.subject | dopamine | |
dc.subject | e4268 | |
dc.subject | epigallocatechin gallate | |
dc.subject | h4381 | |
dc.subject | interleukin 1beta | |
dc.subject | m2128 | |
dc.subject | oxidopamine | |
dc.subject | superoxide dismutase | |
dc.subject | t8532 | |
dc.subject | triton x 100 | |
dc.subject | trypan blue | |
dc.subject | tumor necrosis factor | |
dc.subject | antiinflammatory agent | |
dc.subject | catechin | |
dc.subject | neuroprotective agent | |
dc.subject | oxidopamine | |
dc.subject | tumor necrosis factor inhibitor | |
dc.subject | antiapoptotic activity | |
dc.subject | antiinflammatory activity | |
dc.subject | Article | |
dc.subject | cell culture | |
dc.subject | cell viability | |
dc.subject | clinical evaluation | |
dc.subject | controlled study | |
dc.subject | dopaminergic nerve cell | |
dc.subject | enzyme linked immunosorbent assay | |
dc.subject | experimental parkinsonism | |
dc.subject | human | |
dc.subject | human cell | |
dc.subject | immunocytochemistry | |
dc.subject | immunoreactivity | |
dc.subject | in vitro study | |
dc.subject | morphology | |
dc.subject | MTT assay | |
dc.subject | nerve cell | |
dc.subject | neuroblastoma | |
dc.subject | neuroblastoma cell | |
dc.subject | neuroprotection | |
dc.subject | SK-N-AS cell line | |
dc.subject | statistical analysis | |
dc.subject | apoptosis | |
dc.subject | cell survival | |
dc.subject | Parkinson disease | |
dc.title | Neuroprotective effects of catechins in an experimental Parkinson’s disease model and SK-N-AS cells: evaluation of cell viability, anti-inflammatory and anti-apoptotic effects | |
dc.type | Article |